Increased production of IL-18 and IFN-γ and caspase-1 activation induced by treatment with bLf are important factors contributing to the increase in intestinal mucosal immunity in tumor-bearing mice (Wang W. P. et al., 2000). Here, CASP1 is linked to neoplasm.